As of 2025-07-07, the Relative Valuation of CKD Bio Corp (063160.KS) is 22,993.47 KRW. This relative valuation is based on P/E multiples. With the latest stock price at 22,700.00 KRW, the upside of CKD Bio Corp based on Relative Valuation is 1.3%.
The range of the Relative Valuation is 14,697.40 - 28,848.30 KRW.
| Range | Selected | |
| Trailing P/E multiples | 11.9x - 19.5x | 16.0x |
| Forward P/E multiples | 12.9x - 15.8x | 14.4x |
| Fair Price | 14,697.40 - 28,848.30 | 22,993.47 |
| Upside | -35.3% - 27.1% | 1.3% |
| Date | P/E |
| 2025-04-23 | 18.73 |
| 2025-04-22 | 18.94 |
| 2025-04-21 | 18.33 |
| 2025-04-18 | 18.82 |
| 2025-04-17 | 18.86 |
| 2025-04-16 | 18.86 |
| 2025-04-15 | 18.65 |
| 2025-04-14 | 18.98 |
| 2025-04-11 | 18.94 |
| 2025-04-10 | 18.82 |
| 2025-04-09 | 17.76 |
| 2025-04-08 | 18.00 |
| 2025-04-07 | 17.84 |
| 2025-04-04 | 19.06 |
| 2025-04-03 | 19.71 |
| 2025-04-02 | 19.63 |
| 2025-04-01 | 18.90 |
| 2025-03-31 | 16.13 |
| 2025-03-28 | 16.38 |
| 2025-03-27 | 16.50 |
| 2025-03-26 | 16.50 |
| 2025-03-25 | 16.83 |
| 2025-03-24 | 16.71 |
| 2025-03-21 | 16.71 |
| 2025-03-20 | 16.67 |
| 2025-03-19 | 16.50 |
| 2025-03-18 | 16.26 |
| 2025-03-17 | 16.26 |
| 2025-03-14 | 16.21 |
| 2025-03-13 | 16.21 |
| 2025-03-12 | 16.26 |
| 2025-03-11 | 16.34 |
| 2025-03-10 | 16.54 |
| 2025-03-07 | 16.63 |
| 2025-03-06 | 16.63 |
| 2025-03-05 | 16.63 |
| 2025-03-04 | 16.42 |
| 2025-02-28 | 16.54 |
| 2025-02-27 | 16.95 |
| 2025-02-26 | 16.95 |
| 2025-02-25 | 16.83 |
| 2025-02-24 | 16.87 |
| 2025-02-21 | 16.87 |
| 2025-02-20 | 16.79 |
| 2025-02-19 | 17.03 |
| 2025-02-18 | 17.60 |
| 2025-02-17 | 17.52 |
| 2025-02-14 | 17.19 |
| 2025-02-13 | 16.95 |
| 2025-02-12 | 16.95 |